| Product Name |
MF |
CAS |
Details |
| 2-(tert-butoxycarbonyl)-1,2,3,4- tetrahydroisoquinoline-8-carboxylic acid |
C15H19NO4 |
878798-87-9 |
|
| 1-(1-chlorocyclopropyl)-ethanone |
C5H7ClO |
63141-09-3 |
|
| 13-methyl tetradecanal |
C15H30O |
75853-51-9 |
|
| (2S,4R)-1-(tert-butoxycarbonyl)-4- hydroxypyrrolidine-2-carboxylic acid; N-tert-butoxycarbonyl-L-trans-4- hydroxyproline |
C10H17NO5 |
13726-69-7 |
|
| tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate; Zanubrutinib impurity-16 |
C29H33N5O3 |
2190506-56-8 |
|
| 5-methyl-2-nitrophenol |
C7H7NO3 |
700-38-9 |
|
| 3-Bromo-5-chlorosalicylaldehyde |
C7H4BrClO2 |
19652-32-5 |
|
| 3-tert-butoxycarbonylamino-2-hydroxy- hexanoic acid |
C11H21NO5 |
166196-06-1 |
|
| 3,3,6-trimethylindan-5-ol |
C12H16O |
65021-23-0 |
|
| (R)-tert-butyl (1-fluoro-3-hydroxyl propan-2-yl)carbamate |
C8H16FNO3 |
2378640-83-4 |
|
| 2-chloro-1-(1-chlorocyclopropyl)- ethanone |
C5H6Cl2O |
120983-72-4 |
|
| (R)-3-Hydroxypyrrolidine hydrochloride |
C4H10ClNO |
104706-47-0 |
|
| methyl-4-ethyl-2-methyl-oxazole-5- carboxylate |
C8H11NO3 |
137267-32-4 |
|
| Methyl -1-chloro-cyclopropane carboxylate |
C5H7ClO2 |
1350746-43-8 |
|
| (2S,4S)-4-hydroxypyrrolidine-2- carboxylic acid Hydrochloride; cis-4-Hydroxy-L-proline hydrochloride |
C5H9NO3 |
618-27-9 |
|
| (2S,4S)-4-hydroxypyrrolidine-2- carboxylic acid; cis-4-Hydroxy-L-proline |
C5H9NO3 |
618-27-9 |
|
| Methoxy PEG succinimidyl succinate |
|
78274-32-5 |
|
| 4-hydroxy-3-mesityl-1-oxaspiro [4.4] non-3-en-2-one |
C17H20O3 |
148476-30-6 |
|
| 2,6-bis(chloromethyl)pyridine |
C7H8Cl3N |
55422-79-2 |
|
| 6-bromopyrrolo[1,2-f][1,2,4]triazine- 2,4(1H,3H)-dione |
C6H4BrN3O2 |
1201784-90-8 |
|
| 1-(4-aminophenyl)-3-morpholino-5-6- dihydropyridin-2(1H)-one |
C15H17N3O4 |
503615-03-0 |
|
| 3-Methyl-5-(pyrrolidin-3-yl)-1,2,4-oxadiazole hydrochloride |
C7H12ClN3O |
1121057-52-0 |
|
| Furan-2,5-dicarboxylic acid |
C6H4O5 |
3238-40-2 |
|
| 5-amino-3-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile; Zanubrutinib impurity-20 |
C16H12N4O |
330792-70-6 |
|
| 4-Cyclohexyl-3-(trifluoromethyl)benzyl Alcohol |
C14H17F3O |
957205-23-1 |
|
| 4-bromo-2,6-difluoro-N-methylaniline |
C7H6BrF2N |
93661-77-9 |
|
| ethyl1hydroxycyclopentanecarboxylate |
C8H14O3 |
41248-23-1 |
|
| 4,6-Dichloropyrimidine; Azoxystobin intermediate |
C4H2Cl2N2 |
1193-21-1 |
|
| (2R,4R)-1-(tert-butoxycarbonyl)-4- hydroxypyrrolidine-2-carboxylic acid; N-tert-butoxycarbonyl-D-cis-4- hydroxyproline |
C10H17NO5 |
1218998-83-4 |
|
| tert-butyl 4-(3-cyano-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidin-7-yl)piperidine-1-carboxylate; Zanubrutinib impurity-18 |
C29H29N5O3 |
2190506-55-7 |
|
| 2,4-Difluoro-alpha-(1H-1,2,4- triazolyl)acetophenone; Fluconazole intermediate |
C10H7F2N3O |
86404-63-9 |
|
| R-(+)-2-(4-hydroxyphenoxy) propionic acid |
C9H10O4 |
94050-90-5 |
|
| 4-(p-Tolyloxy) benzonitrile |
C14H11NO |
37563-42-1 |
|
| (S)-2-(4-phenoxyphenyl)-7-(piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; Zanubrutinib impurity-10; |
C24H27N5O2 |
1633352-71-2 |
|
| 7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carbonitrile; Zanubrutinib impurity-8; Cyano impurity |
C27H27N5O2 |
2432022-47-2 |
|
| 2,3-dichloro-6-nitroaniline |
C6H4Cl2N2O2 |
65078-77-5 |
|
| 3,4-difluorobenzoic acid |
C7H4F2O2 |
455-86-7 |
|
| 3-Methyl-5-(pyrrolidin-2-yl)-1,2,4-oxadiazole |
C7H11N3O |
902836-46-8 |
|
| (E)-1-(3-(3,4,5-Trimethoxyphenyl)acryloyl)-5,6-dihydropyridin-2(1H)-one; PPLGM; PIPERLONGUMINE |
C17H19NO5 |
20069-09-4 |
|
| 1,2,3,4-tetrahydroisoquinoline-8- carboxylic acid |
C10H11NO2 |
933753-84-5 |
|
| ((1s,4r)-4-pentyl cyclo hexyl) methanol |
C12H24O |
71458-08-7 |
|
| 2,3-difluoro-1,4-bis(trimethylsilyl) benzene |
C12H20F2Si2 |
867366-94-7 |
|
| 1,2,3,4-tetrahydroisoquinoline-8- carbonitrile |
C10H10N2 |
1203682-31-8 (HCl salt) |
|
| 2-chloropyridin-4-ol |
C5H4ClNO |
17368-12-6 |
|
| 4-PHENOXYPHENYL ISOCYANATE |
C13H9NO2 |
59377-19-4 |
|
| 3-Butyne-1-ol |
C4H6O |
927-74-2 |
|
| N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline; EEDQ |
C14H17NO3 |
16357-59-8 |
|
| (R)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; R-Zanubrutinib; R-isomer |
C27H29N5O3 |
1691249-44-1 |
|
| (R)-pyrrolidin-3-ol |
C4H9NO |
2799-21-5 |
|
| Methyl-2-methyl-2-phenylpropanoate |
C11H14O2 |
57625-74-8 |
|
| Bis (2-chloroethyl) amine .HCl |
C4H10Cl3N |
821-48-7 |
|
| 5-Methoxy-2-nitrobenzaldehyde |
C8H7NO4 |
20357-24-8 |
|
| (2R,4S)-1-(tert-butoxycarbonyl)-4- hydroxypyrrolidine-2-carboxylic acid; N-tert-butoxycarbonyl-D-trans-4- hydroxyproline |
C10H17NO5 |
147266-92-0 |
|
| tert-butyl 4-acetylpiperidine-1-carboxylate; Zanubrutinib impurity-22 |
C12H21NO3 |
206989-61-9 |
|
| 2,6-dibromo-4-(trifluoromethoxy) aniline |
C7H4Br2F3NO |
88149-49-9 |
|
| (2R,4S)-4-hydroxypyrrolidine-2- carboxylic acid Hydrochloride; trans-4-Hydroxy-D-proline hydrochloride |
C5H10ClNO3 |
142347-81-7 |
|
| 7-Octyn-1-ol |
C8H14O |
871-91-0 |
|
| ((1r,4r)-4-methyl cyclohexyl) methanol |
C8H16O |
3937-49-3 |
|
| Methyl-2-methyl-4-phenyl butanoate |
C12H16O2 |
20881-29-2 |
|
| 1-bromo-2,3-difluorobenzene |
C6H3BrF2 |
38573-88-5 |
|
| 4,5-difluorobenzene-1,2-dialdehyde |
C8H4F2O2 |
1398682-68-2 |
|
| ethyl 6-bromo-4-hydroxyquinoline-3- carboxylate |
C12H10BrNO3 |
122794-99-4 |
|
| ((1s,4r)-4-propylcyclohexyl) methanol |
C10H20O |
71458-06-5 |
|
| 1,3-bis(4-cyano-3-(trifluoromethyl)phenyl)thiourea |
C17H8F6N4S |
1839619-50-9 |
|
| 3-Fluoro-5-iodophenol |
C6H4FIO |
939771-60-5 |
|
| 6-chloro-3,4-dihydro-2H-1-benzothiin- 4-one |
C9H7ClOS |
13735-12-1 |
|
| (2R,4R)-methyl 4-hydroxypyrrolidine-2- carboxylate; CIS-4-HYDROXY-D-PROLINE METHYL ESTER |
C6H11NO3 |
114676-47-0 |
|
| 1,5-di(pyridine-2-yl)pentane-1,3,5-trione |
C15H12N2O3 |
128143-87-3 |
|
| 2,3-difluorobenzaldehyde |
C7H4F2O |
2646-91-5 |
|
| tert-butyl (R)-1-(methoxycarbonyl)-2- (benzyloxy)ethylcarbamate |
C16H23NO5 |
67389-47-3 |
|
| 2-(4-phenoxyphenyl)-7-(piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carbonitrile; Zanubrutinib impurity-14; Racemic |
C24H25N5O |
2190506-57-9 |
|
| 7-(1-(3-chloropropanoyl)piperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; Zanubrutinib impurity-3; Zanubrutinib chloro impurity |
C27H30ClN5O3 |
1633351-79-7 |
|
| 2,5-dichlorophenol |
C6H4Cl2O |
583-78-8 |
|
| 4-bromo-2-fluoro-6-nitrophenol |
C6H3BrFNO3 |
320-76-3 |
|
| (S)-pyrrolidin-3-ol |
C4H9NO |
100243-39-8 |
|
| 3,3-dichloro-1-(4-nitrophenyl) piperidin-2- one |
C11H10Cl2N2O3 |
881386-01-2 |
|
| (2S,4R)-4-hydroxypyrrolidine-2- carboxylic acid Hydrochloride; trans-4-Hydroxy-L-proline hydrochloride |
C5H10ClNO3 |
32968-78-8 |
|
| (4-(Pyridin-2-yl)phenyl)MethanaMine hydrochloride |
C12H13ClN2 |
1498333-87-1 |
|
| 3,4-difluorobenzaldehyde |
C7H4F2O |
34036-07-2 |
|
| 2-hydroxybenzonitrile; Azoxystobin intermediate |
C7H5NO |
611-20-1 |
|
| Diethyl cyclopropyl malonate |
C10H16O4 |
42392-68-7 |
|
| (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide; Zanubrutinib API |
C27H29N5O3 |
1691249-45-2 |
|
| 41-bromo-3-phenylpropiophenone |
C15H13BrO |
1669-51-8 |
|
| 4-bromo-1,2-difluorobenzene |
C6H3BrF2 |
348-61-8 |
|
| (2S,4R)-methyl 4-hydroxypyrrolidine-2- carboxylate Hydrochloride; trans-4-HYDROXY-L-PROLINE METHYL ESTER Hydrochloride |
C6H12ClNO3 |
40216-83-9 |
|
| 4-amino-6-(tert-butyl)-3-mercapto- 1,2,4-triazin-5(4H)-one; Butylthione; Metribuzin intermediate |
C7H12N4OS |
33509-43-2 |
|
| (2,3-difluorophenyl)trimethylsilane |
C9H12F2Si |
138871-01-9 |
|
| 1,3-Thiazolidin-2-one |
C3H5NOS |
2682-49-7 |
|
| 4-amino-6-methyl-4,5-dihydro-1,2,4- triazin-3(2H)-one |
C4H8N4O |
123313-07-5 |
|
| 4-(2,4-dichlorophenoxy) aniline |
C12H9Cl2NO |
14861-17-7 |
|
| 2-(2-methyoxyphenyl)-5-oxo tetrahydro Furan-3-carboxylic acid |
C12H12O5 |
117621-06-4 |
|
| 1,2-dibromo-4,5-difluorobenzene |
C6H2Br2F2 |
64695-78-9 |
|
| 6-bromo-4-chloro-N-methylquinolin-3- amine |
|
|
|
| Methyl-14-(2-furyl) tetradeca-11,13- diynoate |
C19H24O3 |
1261455-63-3 |
|
| (4R)-tert-butyl 4-((benzyloxy)methyl)- 1,2,3-oxathiazolidine-3-carboxylate 2- oxide |
|
|
|
| 2,6-difluoro-N-methyl-4-(methyl sulfonyl)aniline |
|
|
|
| (S)-tert-butyl (1-fluoro-3- hydroxypropan-2-yl) carbamate |
|
2378640-84-5 |
|
| methyl 2-((1s,4r)-4-pentylcyclo hexyl)acetate |
|
|
|
| ((1s,4r)-4-propyl cyclohexyl)methyl 4- methylbenzene sulfonate |
|
|
|
| ((1r,4r)-4-methyl cyclohexyl) methyl 4- methyl benzene sulfonate |
|
|
|
